Level C· Early human research exploring benefitsCase Report / SeriesPubMed

When Labiaplasty is Not Enough: Rejuvenation of the Labia Majora Using Hybrid Calcium Hydroxylapatite With Hyaluronic Acid Filler for Increased Satisfaction and Uniform Results.

Caron GF.

Case Report / Series on Face & Skin, published in Aesthet Surg J Open Forum (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
Aesthet Surg J Open Forum (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42529489
DOI
10.1093/asjof/ojag101

Abstract (original English)

Dermal fillers hyaluronic acid (HA) blended with calcium hydroxylapatite-carboxymethylcellulose (CaHA-CMC) for facial indications is increasingly being adapted for body applications, offering both volumizing and regenerative benefits to the skin. In its hyperdilute form, CaHA functions as a regenerative biostimulator, effectively inducing the synthesis of key extracellular matrix components, whereas HA provides immediate volumization. Vaginal rejuvenation, with or without surgery, is also gaining attention with reports of off-label use of fillers for labia majora augmentation; however, analyses of hybrid approaches remain limited. This report outlines a technique utilized in 2 patients in which, following labia minora reduction, the labia majora were volumized using a combination of fillers with the aim of improving both skin quality and enhanced volumetric support. Patients who had previously undergone labiaplasty 6 months prior, presenting with mild-to-moderate laxity of the labia majora, received a single treatment of combined CaHA-CMC and HA injected into the subdermal plane. Outcomes were evaluated after 3 and 20 months for skin texture, firmness, adverse effects, and patient satisfaction levels. Posttreatment, improvements to skin quality, flaccidity, volumization, and dermal integrity were observed for both patients. High patient satisfaction was similarly reported, alon

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research